Drug Discovery 2030: A Roadmap for a New Decade Esta formação não está ativa.
Erasmus+ Blended Intensive Programmes are teaching/learning elements jointly delivered by several universities, combining virtual components with short-term physical mobility. The training is planned under the Blended Intensive Programme (BIP) rules. It is a joint programme of four programme universities, from three different countries, where learners come together. It includes both a physical activity and an online component. The coordinating HEI is UP.
The course is focused in Drug Discovery and aims to bring together renowned researchers from academy and industry that will exchange and share their experiences on the field, mainly in the following subjects Drug Discovery Strategies, New Modalities in Drug Discovery, Tackling Challenges in Drug Discovery and Preclinical Drug Discovery and Moving from Academia to Industry. Based on real-world experience and practical realities, attendees will travel step-by step along the typical path of the multidisciplinary nature of Drug Discovery. Conjointly the Drug Discovery course aims to create awareness and to provide a perfect platform for the participants to upgrade their knowledge and experience and to discuss on the ways to foster the exchange of concepts, prototypes, research ideas and the research work.
This course reflects the current focus of global research, recent developments, interdisciplinary research and practices in the fields of Drug Discovery.
